Page last updated: 2024-08-23

etoposide and Esophageal Squamous Cell Carcinoma

etoposide has been researched along with Esophageal Squamous Cell Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Boku, N; Daiko, H; Hirano, H; Honma, Y; Inaba, K; Itami, J; Ito, Y; Iwasa, S; Kanamori, J; Kato, K; Murakami, N; Nagashima, K; Oguma, J; Okita, N; Shoji, H; Takashima, A	1
Endo, M; Fukuda, K; Hasegawa, N; Hattori, J; Hirose, S; Hyodo, I; Ishige, K; Kawai, H; Komatsu, Y; Mizokami, Y; Mizui, T; Nagase, M; Sato, M; Yamamoto, Y; Yamaura, M	1
Bokhyan, V; Davydov, M; Fedyanin, M; Kononets, P; Malikhova, O; Minin, K; Pokataev, I; Shogenov, M; Stilidi, I; Tjulandin, S; Tryakin, A; Vybarava, A	1

Trials

1 trial(s) available for etoposide and Esophageal Squamous Cell Carcinoma

Article	Year
Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study. Japanese journal of clinical oncology, 2016, Volume: 46, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies	2016

Article

Year

Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study.

Japanese journal of clinical oncology, 2016, Volume: 46, Issue:7

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoadjuvant Therapy; Prospective Studies

2016

Other Studies

2 other study(ies) available for etoposide and Esophageal Squamous Cell Carcinoma

Article	Year
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy. Cancer medicine, 2020, Volume: 9, Issue:2 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate	2020
Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma. Internal medicine (Tokyo, Japan), 2020, Oct-15, Volume: 59, Issue:20 Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Humans; Lymph Nodes; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy; Treatment Outcome	2020

Article

Year

Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy.

Cancer medicine, 2020, Volume: 9, Issue:2

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate

2020

Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma.

Internal medicine (Tokyo, Japan), 2020, Oct-15, Volume: 59, Issue:20

Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Etoposide; Female; Humans; Lymph Nodes; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Radiotherapy; Treatment Outcome

2020